Eye

EQS-News: Amprion accelerates grid expansion and invests more than ever before

Retrieved on: 
Friday, May 3, 2024
RAB, Investment, Ultranet, Depreciation, Annual report, Brick, Sustainalytics, CSRD, Tax, Eye, ESG, Transformation, Workforce, Growth, Amprion, Climate, Renewable energy

Transmission system operator Amprion is stepping up the pace of grid expansion and continues to grow.

Key Points: 
  • Transmission system operator Amprion is stepping up the pace of grid expansion and continues to grow.
  • By 2028 Amprion plans to invest around €27.5 billion in the expansion and upgrading of the transmission grid.
  • “The statutory measures introduced to accelerate grid expansion are having an impact.
  • Amprion has tripled its investments in grid expansion since 2021.

The Next Pipedrive in Sales Execution, Salesforge Secures $500k in Pre-Seed Funding to Build a Future-Proof AI Co-Pilot in B2B Sales

Retrieved on: 
Tuesday, April 16, 2024
CRM, Language, Pipedrive, B2B, Hunger, Eye, Growth, Sales

"We believe that the sales teams of tomorrow are going to be very lean and execution will be more programmatic, which will drive significant conversion lift across the sales funnel.

Key Points: 
  • "We believe that the sales teams of tomorrow are going to be very lean and execution will be more programmatic, which will drive significant conversion lift across the sales funnel.
  • For now, Salesforge has two products - Salesforge and Mailforge, which, when taken together, address both of these challenges.
  • "Salesforge capitalizes on an opportunity in a market that currently sees tectonic shifts leveling the playing field for new entrants.
  • Looking forward, Salesforge wants to become an AI-age ecosystem of sales tools known as forges for B2B sales teams, on par with another regional success story, Pipedrive, which became a unicorn by redefining the CRM landscape.

Three More Ambassadors Join King Kanu at Sportsbet.io

Retrieved on: 
Sunday, April 14, 2024
Volleyball, Blockchain, Eye, Music, Arsenal, Cryptocurrency

The new signings are part of the crypto sports betting site's global team, led by Nigerian football legend Nwankwo Kanu

Key Points: 
  • London, United Kingdom--(Newsfile Corp. - April 13, 2024) - Sportsbet.io has announced three more high-profile ambassadors, all 'joining the crypto experience' alongside a team of superstars that already includes Nwankwo Kanu, Brett Lee and King Kaka.
  • Brian, Yaron and Edikan join the Sportsbet.io team as part of an ongoing campaign to recruit the best ambassadors in the world of sports betting.
  • "I'm delighted to see more ambassadors join the crypto experience with Sportsbet.io.
  • If a natural-born networker who thinks they have what it takes to join Kanu, please visit the official jointhecryptoexperience.site here .

Bombardier Reports Significant Backlog Growth on 1.6 Unit Book-to-Bill, Expanded Margins and Service Revenues Increase in First Quarter of 2024

Retrieved on: 
Thursday, April 25, 2024
Aircraft, Table, Service, PP, Note, Hand, TSX, MD, Growth, PP&E, Martel, Bombardier Inc., Senior, Eye, EPS, Movement, Bank statement

MONTRÉAL, April 25, 2024 (GLOBE NEWSWIRE) -- Bombardier Inc. (TSX: BBD.B) reported today its financial results for the first quarter of 2024, marked by a robust increase in service revenues and order activity.

Key Points: 
  • MONTRÉAL, April 25, 2024 (GLOBE NEWSWIRE) -- Bombardier Inc. (TSX: BBD.B) reported today its financial results for the first quarter of 2024, marked by a robust increase in service revenues and order activity.
  • The company sold 60% more jets in the first quarter of 2024 compared to 2023, bringing backlog(5) up to $14.9 billion.
  • “Our team came flying out of the gates in 2024 on soaring aircraft orders and service revenues.
  • Orders remained strong across Bombardier’s portfolio of aircraft, recording a 60% increase compared to the same quarter last year.

Blackwell 3D Launches New Website, Eyes Project Development

Retrieved on: 
Thursday, April 25, 2024
Construction, News, OTC, Communication, 3D, Life, Eye, FAQ, Online shopping

The revamped website, accessible at www.blackwell3d.com , represents a significant milestone in Blackwell 3D's commitment to delivering cutting-edge solutions and bringing new ideas to life like never before.

Key Points: 
  • The revamped website, accessible at www.blackwell3d.com , represents a significant milestone in Blackwell 3D's commitment to delivering cutting-edge solutions and bringing new ideas to life like never before.
  • The site, www.blackwell3d.com , incorporates numerous features to make browsing a more streamlined and informative experience for all viewers.
  • As our primary method of communication, our new website accurately reflects the progress and innovation we continue to make as we advance the company to the project development stage,” stated Mohammed Saif Zaveri, CEO of Blackwell 3D.
  • As technology continues to reshape traditional industries, Blackwell 3D seeks to be a pioneer in leveraging the latest advancements to deliver unparalleled solutions to its clients.

Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting

Retrieved on: 
Wednesday, April 24, 2024
Grand Hyatt Seattle, Srinivas, Research, Diabetic retinopathy, PDT, MD, Doctor of Philosophy, Artificial intelligence, Booth, Neuro-ophthalmology, Eye, Breakfast, RSVP, Seattle Convention Center, Annual general meeting, Doheny Eye Institute, Pine Street, Imaging, ARVO, Knowledge

PASADENA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, announced that more than 25 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, the premiere gathering for eye and vision scientists from across the globe.

Key Points: 
  • PASADENA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, announced that more than 25 of its scientists and clinician-scientists will present their latest research during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, the premiere gathering for eye and vision scientists from across the globe.
  • Doheny Eye Institute and UCLA Stein Eye Institute will also be exhibiting together onsite at Booth #4515.
  • “Doheny Eye Institute is eager to share our latest findings and exchange insights with other leaders in vision research during the ARVO Annual Meeting,” said Deborah A. Ferrington, PhD, Chief Scientific Officer at Doheny Eye Institute.
  • At the conclusion of ARVO 2024, SriniVas R. Sadda, MD, the Director of Artificial Intelligence & Imaging Research at Doheny, will officially step into his role as President of ARVO.

PAINWeek 2024 to Spotlight Real-World Patient's Journey: From Career-Ending Injury to Pain Triumph

Retrieved on: 
Wednesday, April 24, 2024
Dream, Pain, Eye, Patient, Cosmopolitan, Knowledge

Boca Raton, FL, April 24, 2024 (GLOBE NEWSWIRE) -- PAINWeek , a respected leader in continuing medical education, announces its nationally recognized keynote speaker—a real pain patient sharing his healing journey—at The Cosmopolitan of Las Vegas from September 3-6.

Key Points: 
  • Boca Raton, FL, April 24, 2024 (GLOBE NEWSWIRE) -- PAINWeek , a respected leader in continuing medical education, announces its nationally recognized keynote speaker—a real pain patient sharing his healing journey—at The Cosmopolitan of Las Vegas from September 3-6.
  • This year's agenda will include patient testimony and real-life cases to help attendees bridge the gap between knowledge and clinical application.
  • Introducing the Real-World Patient Keynote:
    Charles Clark, once celebrated as one of the world's fastest men, faced such adversity at a young age.
  • With national victories and participation in global championships, he stood on the brink of a promising career until a career-ending injury shattered his dreams, leaving him feeling purposeless.

Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma

Retrieved on: 
Tuesday, April 23, 2024
Monitoring, Cancer, Patient, Inflammation, Safety, Radiation, SJD, The Study, Therapy, Vice, Eye, Sant Joan, Enucleation of the eye, Pharmaceutical industry

ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced positive topline data from the investigator sponsored Phase 1 trial conducted by collaborators at Sant Joan de Déu-Barcelona Children’s Hospital (SJD). The Phase 1 trial was designed to evaluate the safety and tolerability of two intravitreal injections of Theriva’s investigational oncolytic adenovirus VCN-01 in patients (n=9) with intraocular retinoblastoma that is refractory to chemotherapy or radiotherapy, and for whom enucleation was the only recommended treatment.

Key Points: 
  • “Results from the investigator sponsored trial further validate VCN-01’s unique mechanism of action and therapeutic potential to improve patient outcomes in otherwise refractory cancers,” said Steven A. Shallcross, Chief Executive Officer of Theriva Biologics.
  • “We look forward to building on the encouraging safety profile and antitumor activity, which further supports and informs the design of our proposed Phase 2 clinical trial.
  • The Monitoring Committee determined that the trial results were positive, and therefore, Theriva will receive an exclusive, worldwide license, and related patents from SJD for the treatment of pediatric patients with advanced retinoblastoma.
  • Eye enucleation was avoided in 3 patients to date, one of whom has retained their eye after 4 years of follow-up.

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Retrieved on: 
Monday, April 22, 2024
CRSP, CRISPR, LNP, MD, Cell, Messenger, Eye, Gene, Society, MYOC, Annual general meeting, Glaucoma

The abstract describes our proprietary capabilities to deliver to and edit genes in the eye, opening a potential new focus area.

Key Points: 
  • The abstract describes our proprietary capabilities to deliver to and edit genes in the eye, opening a potential new focus area.
  • Multiple LNPs as well as modified gRNAs and mRNAs were screened to achieve maximal editing in vivo.
  • In human primary trabecular meshwork cells, up to 95% MYOC editing and 85% protein knockdown were seen.
  • A copy of the presentation will be available at www.crisprtx.com once the presentation concludes.

Chinese Canadian Museum Takes Highlights of Feature Exhibition “The Paper Trail to the 1923 Chinese Exclusion Act” on the Road

Retrieved on: 
Thursday, April 18, 2024
Chinese Exclusion Act, Courage, Canadian Museum of History, CCM, City, Toronto Reference Library, Fear, Chinese Canadians, Pier, Exhibition, Perseverance, C.I, History, Museum, Paper Trail, Room, Eye, Catherine Clément, Community, Government, Gatineau, Tourism

VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- The Chinese Canadian Museum (CCM) is pleased to announce they will be taking highlights of their feature exhibition The Paper Trail to the 1923 Chinese Exclusion Act on the road across Canada this May in recognition of Asian Heritage Month. A special video tour of the national exhibition located in the museum’s historic Wing Sang Building has been produced especially for this East Coast tour.

Key Points: 
  • Photo: Curator Catherine Clement presenting the Chinese Canadian Museum’s feature exhibition “The Paper Trail to the 1923 Chinese Exclusion Act” during the museum’s grand opening on July 1, 2023.
  • VANCOUVER, British Columbia, April 18, 2024 (GLOBE NEWSWIRE) -- The Chinese Canadian Museum (CCM) is pleased to announce they will be taking highlights of their feature exhibition The Paper Trail to the 1923 Chinese Exclusion Act on the road across Canada this May in recognition of Asian Heritage Month.
  • As Canada’s first Chinese Canadian Museum, the museum provides a meaningful and transformative experience for all, connecting Canadians to the diverse and eclectic stories and contributions of generations of Chinese Canadians, past and present — with an eye to the future.
  • Catherine Clement is an award-winning community curator whose work focuses on uncovering and sharing the lesser-known stories of the Chinese Canadian community.